| 注册
首页|期刊导航|现代妇产科进展|宫颈癌新辅助化疗敏感性的影响因素研究

宫颈癌新辅助化疗敏感性的影响因素研究

赵晓南 张虹

现代妇产科进展Issue(7):498-500,3.
现代妇产科进展Issue(7):498-500,3.DOI:10.13283/j.cnki.xdfckjz.2015.07.006

宫颈癌新辅助化疗敏感性的影响因素研究

Factors associated with sensitivity of neoadjuvant chemotherapy in cervical cancer

赵晓南 1张虹2

作者信息

  • 1. 天津医科大学,天津 300070
  • 2. 天津市中心妇产科医院,天津 300052
  • 折叠

摘要

Abstract

Objective:To explore the effective factors for sensitivity of neoadjuvant chemotherapy( NACT) in cervical cancer. Methods:Stage IB2 to IIB disease was present in 106 patients which were all undertaken 1~3 courses of NACT and radical hysterectomy in our hos-pital during Apr. 2011 and Feb. 2015. Efficacy was evaluated preoperatively. To analyze the re-lationship of NACT sensitivity with pathological type,clinical stage,tumor diameter,grade of dif-ferentiation,pretreatment level of serum squamous cell carcinoma antigen ( SCC-Ag) ,hemoglo-bin,platelets,platelet and lymphocyte ratio (PLR). Results:The efficiency was 64. 15%(68/106 ) . Time of operation and the rate of lymph node metastasis and cervical deep stromal infil-tration in effective group was significantly lower than that in invalid group(P<0. 05). Univariate analysis showed that pretreatment tumor diameter, SCC-Ag, PLR was significantly related to NACT sensitivity(P<0. 05). Multivariate analysis showed those pretreatment tumor diameter, SCC-Ag,PLR were independently correlated with NACT sensitivity in cervical cancer ( P<0. 05). Conclusions:Pretreatment tumor diameter,SCC-Ag and PLR showed potentially predic-tive value of NACT sensitivity in cervical cancer.

关键词

宫颈癌/新辅助化疗/敏感性/血小板与淋巴细胞比值

Key words

Cervical cancer/Neoadjuvant chemotherapy(NACT)/Sensitivity/Platelet and lymphocyte ratio( PLR)

分类

医药卫生

引用本文复制引用

赵晓南,张虹..宫颈癌新辅助化疗敏感性的影响因素研究[J].现代妇产科进展,2015,(7):498-500,3.

现代妇产科进展

OA北大核心CSCDCSTPCD

1004-7379

访问量0
|
下载量0
段落导航相关论文